Managing Diabetes During the COVID-19 Pandemic.

Q2 Medicine European Endocrinology Pub Date : 2020-10-01 Epub Date: 2020-10-06 DOI:10.17925/EE.2020.16.2.85
John Doupis, Konstantinos Avramidis
{"title":"Managing Diabetes During the COVID-19 Pandemic.","authors":"John Doupis, Konstantinos Avramidis","doi":"10.17925/EE.2020.16.2.85","DOIUrl":null,"url":null,"abstract":"<p><p>The coronavirus disease 2019 (COVID-19) pandemic has affected almost every country in the world and has changed the way we access healthcare. People with pre-existing conditions, such as diabetes, are at high risk of a severe disease course and it is essential that, as well as good hygiene and social distancing measures, blood glucose is carefully monitored, as chronic hyperglycaemia can lead to immune dysfunction. People with diabetes should be encouraged to continue medication prescribed for hypertension, diabetes or dyslipidaemia. Furthermore, patients with diabetes and COVID-19 infection should follow their usual antidiabetic treatment with the exception of sodium-glucose cotransporter-2 inhibitors. As the current pandemic situation has rendered some patients unable to access routine healthcare, telehealth may help those with travel restrictions.</p>","PeriodicalId":38860,"journal":{"name":"European Endocrinology","volume":"16 2","pages":"85-87"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572158/pdf/euendo-16-85.pdf","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/EE.2020.16.2.85","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/10/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 26

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected almost every country in the world and has changed the way we access healthcare. People with pre-existing conditions, such as diabetes, are at high risk of a severe disease course and it is essential that, as well as good hygiene and social distancing measures, blood glucose is carefully monitored, as chronic hyperglycaemia can lead to immune dysfunction. People with diabetes should be encouraged to continue medication prescribed for hypertension, diabetes or dyslipidaemia. Furthermore, patients with diabetes and COVID-19 infection should follow their usual antidiabetic treatment with the exception of sodium-glucose cotransporter-2 inhibitors. As the current pandemic situation has rendered some patients unable to access routine healthcare, telehealth may help those with travel restrictions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在COVID-19大流行期间管理糖尿病。
2019年冠状病毒病(COVID-19)大流行几乎影响了世界上每个国家,并改变了我们获得医疗保健的方式。患有糖尿病等既往疾病的人患严重疾病的风险很高,除了保持良好的卫生和社交距离措施外,还必须仔细监测血糖,因为慢性高血糖会导致免疫功能障碍。应鼓励糖尿病患者继续服用治疗高血压、糖尿病或血脂异常的药物。此外,糖尿病和COVID-19感染患者应遵循除钠-葡萄糖共转运蛋白-2抑制剂外的常规降糖治疗。由于目前的大流行局势使一些患者无法获得常规保健,远程保健可能有助于那些旅行受到限制的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Endocrinology
European Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
期刊最新文献
ADA-EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective. Clinical Profile and Factors Associated with Adverse Outcomes in Coronavirus Disease 2019-associated Mucormycosis: A Single-centre Study. What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review. Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the Horizon. Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1